Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Abstract

Background Psoriasis has substantial psychological and emotional effects. We assessed the effect of etanercept, an effective treatment for the clinical symptoms of psoriasis, on fatigue and symptoms of depression associated with the condition. Methods 618 patients with moderate to severe psoriasis received double-blind treatment with placebo or 50 mg twice-weekly etanercept. The primary efficacy endpoint was a 75% or greater improvement from baseline in psoriasis area and severity index score (PASI 75) at week 12. Secondary and other endpoints included the functional assessment of chronic illness therapy fatigue (FACIT-F) scale, the Hamilton rating scale for depression (Ham-D), the Beck depression inventory (BDI), and adverse events. Efficacy analyses were based on the allocated treatment. Analyses and summaries of safety data were based on the actual treatment received. This study is registered with with the identifier NCT00111449. Findings 47% (147 of 311) of patients achieved PASI 75 at week 12, compared with 5% (15 of 306) of those receiving placebo (p Interpretation Etanercept treatment might relieve fatigue and symptoms of depression associated with this chronic disease.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(05)67763-x

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 40 references

Cited by

See all 1,069

Metadata

Authors
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., Cella, D., & Krishnan, R.
Affiliations
  • The University of Texas Health Science Center at Houston (US)
  • Rutgers, The State University of New Jersey (US)
  • Western University (CA)
  • Saint Louis University (US)
  • Amgen (United States) (US)
  • Northwestern University (US)
  • Duke University (US)
Corresponding author
Krishnan, Ranga
Venue
The Lancet
Publisher
Elsevier BV
Published
2006-01
Volume
367
Issue
9504
Pages
29-35
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2168911501
Cited by
1,069
References
40
Citations by year
2026: 12 · 2025: 22 · 2024: 34 · 2023: 36 · 2022: 48 · 2021: 44 · 2020: 70 · 2019: 55 · 2018: 69 · 2017: 51 · 2016: 68 · 2015: 71 · 2014: 65 · 2013: 72 · 2012: 69
FWCI
11.71
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
Amgen
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Keywords
etanercept, psoriasis, fatigue, depression, TNF-alpha inhibitors, PASI 75, FACIT-Fatigue, Hamilton Depression Rating Scale, Beck Depression Inventory, joint pain
MeSH terms
Etanercept, Anti-Inflammatory Agents, Non-Steroidal, Depression, Double-Blind Method, Fatigue, Female, Humans, Immunoglobulin G, Male, Middle Aged, Psoriasis, Severity of Illness Index, Receptors, Tumor Necrosis Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. https://app.cochat.ai/papers/10.1016/s0140-6736(05)67763-x
The paper
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., Cella, D., & Krishnan, R. (2006). Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. The Lancet. https://doi.org/10.1016/s0140-6736(05)67763-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.